Charles P. Gerba, PhD: “Unfortunately, standard procedures for testing and registration by regulatory agencies of CADs (continuously active sanitizers or disinfectants) as disinfectants useful in preventing exposure to disease causing microorganism transmission has only taken place in recent years.”
Currently, the United States Environmental Protection Agency (EPA) registered products that claim long-lasting effectiveness are limited to those that control odor-causing bacteria on hard non-porous surfaces. The agency is currently reassessing changes that may allow such claims in response to the current coronavirus disease 2019 (COVID-19) pandemic. Unfortunately, standard procedures for testing and registration by regulatory agencies of continuously active sanitizers or disinfectants (CADs) as disinfectants useful in preventing exposure to disease causing microorganism transmission has only taken place in recent years.
Charles P. Gerba, PhD
The EPA developed a protocol for evaluating bactericidal activity on nonporous copper containing surface alloys and one-for-one for claiming a residual self-sanitizing activity of dried chemicals on hard, non-poroud surfaces. These methods also simulate contact and touching by incorporating “wear” of the test surface as well as re-inoculation of the test microorganism. However, more progress is needed in this area to develop standard procedures that would also allow a better reflection of the advantages in terms of benefits in reducing the risk of infection with treated surfaces.
Quantitative microbial risk assessment is an approach that has been used to demonstrate reduced risk of infection from a continuous acting hand sanitizer over time. Using this approach, it was demonstrated that four hours after hand application the sanitizer reduced the probability of infection if the hand was re-contaminated with norovirus by 78%.
Recent epidemiological studies have suggested that CADs can reduce the bacterial bioburden on surfaces in healthcare environments and hospital acquired infections. Assessment of a quaternary ammonium polymer coating in intensive car units was found to result in the absence of antibiotic resistant bacteria on surfaces for three months in one study and in a follow-up study a 36% decline in hospital-acquired infection (HAI) was observed. Several studies with copper surfaces have also shown similar results and suggested a reduction in HAIs in hospitals.
The potential for CADs has taken on new importance with the Covid-19 pandemic. Protecting exposure via surfaces in facilities used by large numbers of individuals becomes challenging. This is especially true in schools, universities, mass transport, recreational facilities, etc. The amount of resources and practicality of disinfecting facilities between use by different individuals appears insurmountable in many cases. Recent studies have shown that SARS-CoV-2 that CADs can be effective against this virus both on hard surfaces and fabrics and may be useful in filling this need.
CHARLES P. GERBA, PhD, is a professor of environmental microbiology in the Department of Environmental Science, and Environmental and Community Health at the University of Arizona. He serves on the Advisory Boards of PDI and Allied Bioscience.
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.